Cargando…
Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs)
BACKGROUND: Cowpea Mosaic Virus (CPMV) is increasingly being used as a nanoparticle platform for multivalent display of molecules via chemical bioconjugation to the capsid surface. A growing variety of applications have employed the CPMV multivalent display technology including nanoblock chemistry,...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551747/ https://www.ncbi.nlm.nih.gov/pubmed/18830402 http://dx.doi.org/10.1371/journal.pone.0003315 |
_version_ | 1782159468046319616 |
---|---|
author | Rae, Chris Koudelka, Kristopher J. Destito, Giuseppe Estrada, Mayra N. Gonzalez, Maria J. Manchester, Marianne |
author_facet | Rae, Chris Koudelka, Kristopher J. Destito, Giuseppe Estrada, Mayra N. Gonzalez, Maria J. Manchester, Marianne |
author_sort | Rae, Chris |
collection | PubMed |
description | BACKGROUND: Cowpea Mosaic Virus (CPMV) is increasingly being used as a nanoparticle platform for multivalent display of molecules via chemical bioconjugation to the capsid surface. A growing variety of applications have employed the CPMV multivalent display technology including nanoblock chemistry, in vivo imaging, and materials science. CPMV nanoparticles can be inexpensively produced from experimentally infected cowpea plants at high yields and are extremely stable. Although CPMV has not been shown to replicate in mammalian cells, uptake in mammalian cells does occur in vitro and in vivo. Thus, inactivation of the virus RNA genome is important for biosafety considerations, however the surface characteristics and chemical reactivity of the particles must be maintained in order to preserve chemical and structural functionality. METHODOLOGY/PRINCIPAL FINDINGS: Short wave (254 nm) UV irradiation was used to crosslink the RNA genome within intact particles. Lower doses of UV previously reported to inactivate CPMV infectivity inhibited symptoms on inoculated leaves but did not prohibit systemic virus spread in plants, whereas higher doses caused aggregation of the particles and an increase in chemical reactivity further indicating broken particles. Intermediate doses of 2.0–2.5 J/cm(2) were shown to maintain particle structure and chemical reactivity, and cellular binding properties were similar to CPMV-WT. CONCLUSIONS: These studies demonstrate that it is possible to inactivate CPMV infectivity while maintaining particle structure and function, thus paving the way for further development of CPMV nanoparticles for in vivo applications. |
format | Text |
id | pubmed-2551747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-25517472008-10-02 Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs) Rae, Chris Koudelka, Kristopher J. Destito, Giuseppe Estrada, Mayra N. Gonzalez, Maria J. Manchester, Marianne PLoS One Research Article BACKGROUND: Cowpea Mosaic Virus (CPMV) is increasingly being used as a nanoparticle platform for multivalent display of molecules via chemical bioconjugation to the capsid surface. A growing variety of applications have employed the CPMV multivalent display technology including nanoblock chemistry, in vivo imaging, and materials science. CPMV nanoparticles can be inexpensively produced from experimentally infected cowpea plants at high yields and are extremely stable. Although CPMV has not been shown to replicate in mammalian cells, uptake in mammalian cells does occur in vitro and in vivo. Thus, inactivation of the virus RNA genome is important for biosafety considerations, however the surface characteristics and chemical reactivity of the particles must be maintained in order to preserve chemical and structural functionality. METHODOLOGY/PRINCIPAL FINDINGS: Short wave (254 nm) UV irradiation was used to crosslink the RNA genome within intact particles. Lower doses of UV previously reported to inactivate CPMV infectivity inhibited symptoms on inoculated leaves but did not prohibit systemic virus spread in plants, whereas higher doses caused aggregation of the particles and an increase in chemical reactivity further indicating broken particles. Intermediate doses of 2.0–2.5 J/cm(2) were shown to maintain particle structure and chemical reactivity, and cellular binding properties were similar to CPMV-WT. CONCLUSIONS: These studies demonstrate that it is possible to inactivate CPMV infectivity while maintaining particle structure and function, thus paving the way for further development of CPMV nanoparticles for in vivo applications. Public Library of Science 2008-10-02 /pmc/articles/PMC2551747/ /pubmed/18830402 http://dx.doi.org/10.1371/journal.pone.0003315 Text en Rae et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Rae, Chris Koudelka, Kristopher J. Destito, Giuseppe Estrada, Mayra N. Gonzalez, Maria J. Manchester, Marianne Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs) |
title | Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs) |
title_full | Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs) |
title_fullStr | Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs) |
title_full_unstemmed | Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs) |
title_short | Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs) |
title_sort | chemical addressability of ultraviolet-inactivated viral nanoparticles (vnps) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551747/ https://www.ncbi.nlm.nih.gov/pubmed/18830402 http://dx.doi.org/10.1371/journal.pone.0003315 |
work_keys_str_mv | AT raechris chemicaladdressabilityofultravioletinactivatedviralnanoparticlesvnps AT koudelkakristopherj chemicaladdressabilityofultravioletinactivatedviralnanoparticlesvnps AT destitogiuseppe chemicaladdressabilityofultravioletinactivatedviralnanoparticlesvnps AT estradamayran chemicaladdressabilityofultravioletinactivatedviralnanoparticlesvnps AT gonzalezmariaj chemicaladdressabilityofultravioletinactivatedviralnanoparticlesvnps AT manchestermarianne chemicaladdressabilityofultravioletinactivatedviralnanoparticlesvnps |